- Category: Medical Cannabis News
- Published: Monday, 15 September 2014 11:07
A study published this month by the journal Cell Biochemistry and Function, and published online by the U.S. National Institute of Health, has found promising evidence to suggest that delta-9-tetrahydrocannabinol (THC) may provide a safe and effective treatment option for those with diabetes.
For the study; “Rats were randomly divided into four groups: control, Δ9 -THC, diabetes and diabetes + Δ9 -THC groups. Δ9 -THC was administered intraperitoneally [through injection] at 3 mg/kg/day for 7 days. Body weights and blood glucose level of rats in all groups were measured on days 0, 7, 14 and 21.”